Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garry R Cutting

Showing results (81-90 of 158) with videos related to

Pageof 16
Sort By:
Cellular & Molecular Biology Letters|May 25, 2017
Codon bias and the folding dynamics of the cystic fibrosis transmembrane conductance regulatorRafal Bartoszewski, Jaroslaw Króliczewski, Arkadiusz Piotrowski, et al.
Nature Genetics|October 2, 2024
Standardizing variant naming in literature with VariantValidator to increase diagnostic ratesPeter J Freeman, John F Wagstaff, Ivo F A C Fokkema, et al.
Plos Genetics|March 23, 2012
Variation in MSRA modifies risk of neonatal intestinal obstruction in cystic fibrosisLindsay B Henderson, Vishal K Doshi, Scott M Blackman, et al.
Nature Genetics|October 30, 2024
Author Correction: Standardizing variant naming in literature with VariantValidator to increase diagnostic ratesPeter J Freeman, John F Wagstaff, Ivo F A C Fokkema, et al.
European Journal of Human Genetics : EJHG|January 14, 2010
Use of a modeling framework to evaluate the effect of a modifier gene (MBL2) on variation in cystic fibrosisKathryn E McDougal, Deanna M Green, Lori L Vanscoy, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 6, 2021
SLC26A9 SNP rs7512462 is not associated with lung disease severity or lung function response to ivacaftor in cystic fibrosis patients with G551D-CFTRAlice C Eastman, Rhonda G Pace, Hong Dang, et al.
Human Genome Variation|December 6, 2016
Deep resequencing of <i>CFTR</i> in 762 F508del homozygotes reveals clusters of non-coding variants associated with cystic fibrosis disease traitsBriana Vecchio-Pagán, Scott M Blackman, Melissa Lee, et al.
The Journal of Clinical Investigation|October 4, 2019
Increased expression of anion transporter SLC26A9 delays diabetes onset in cystic fibrosisAnh-Thu N Lam, Melis A Aksit, Briana Vecchio-Pagan, et al.
American Journal of Respiratory and Critical Care Medicine|March 3, 2007
Heritability of lung disease severity in cystic fibrosisLori L Vanscoy, Scott M Blackman, Joseph M Collaco, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|October 16, 2019
Cystic fibrosis transmembrane conductance regulator modulators reduce the risk of recurrent acute pancreatitis among adult patients with pancreas sufficient cystic fibrosisVenkata S Akshintala, Ayesha Kamal, Mahya Faghih, et al.
Pageof 16

Showing results (81-90 of 158) with videos related to

Sort By:
Pageof 16
Cellular & Molecular Biology Letters|May 25, 2017
Codon bias and the folding dynamics of the cystic fibrosis transmembrane conductance regulatorRafal Bartoszewski, Jaroslaw Króliczewski, Arkadiusz Piotrowski, et al.
Nature Genetics|October 2, 2024
Standardizing variant naming in literature with VariantValidator to increase diagnostic ratesPeter J Freeman, John F Wagstaff, Ivo F A C Fokkema, et al.
Plos Genetics|March 23, 2012
Variation in MSRA modifies risk of neonatal intestinal obstruction in cystic fibrosisLindsay B Henderson, Vishal K Doshi, Scott M Blackman, et al.
Nature Genetics|October 30, 2024
Author Correction: Standardizing variant naming in literature with VariantValidator to increase diagnostic ratesPeter J Freeman, John F Wagstaff, Ivo F A C Fokkema, et al.
European Journal of Human Genetics : EJHG|January 14, 2010
Use of a modeling framework to evaluate the effect of a modifier gene (MBL2) on variation in cystic fibrosisKathryn E McDougal, Deanna M Green, Lori L Vanscoy, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 6, 2021
SLC26A9 SNP rs7512462 is not associated with lung disease severity or lung function response to ivacaftor in cystic fibrosis patients with G551D-CFTRAlice C Eastman, Rhonda G Pace, Hong Dang, et al.
Human Genome Variation|December 6, 2016
Deep resequencing of <i>CFTR</i> in 762 F508del homozygotes reveals clusters of non-coding variants associated with cystic fibrosis disease traitsBriana Vecchio-Pagán, Scott M Blackman, Melissa Lee, et al.
The Journal of Clinical Investigation|October 4, 2019
Increased expression of anion transporter SLC26A9 delays diabetes onset in cystic fibrosisAnh-Thu N Lam, Melis A Aksit, Briana Vecchio-Pagan, et al.
American Journal of Respiratory and Critical Care Medicine|March 3, 2007
Heritability of lung disease severity in cystic fibrosisLori L Vanscoy, Scott M Blackman, Joseph M Collaco, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|October 16, 2019
Cystic fibrosis transmembrane conductance regulator modulators reduce the risk of recurrent acute pancreatitis among adult patients with pancreas sufficient cystic fibrosisVenkata S Akshintala, Ayesha Kamal, Mahya Faghih, et al.
Pageof 16